**Core Concept**
Esophageal adenocarcinoma is a subtype of esophageal cancer, primarily affecting the esophageal mucosa. The pathogenesis involves chronic gastroesophageal reflux disease (GERD), leading to Barrett's esophagus, a precursor lesion.

**Why the Correct Answer is Right**
The most common site of esophageal adenocarcinoma is the lower third of the esophagus, specifically the gastroesophageal junction (GEJ). This is attributed to the frequent exposure of the esophageal mucosa to gastric acid reflux, leading to chronic inflammation and metaplastic changes. The presence of Barrett's esophagus, characterized by intestinal-type metaplasia of the esophageal mucosa, increases the risk of adenocarcinoma development. The lower esophageal sphincter's (LES) incompetence and the resulting acid reflux facilitate the progression of Barrett's esophagus to adenocarcinoma.

**Why Each Wrong Option is Incorrect**
**Option A:** The upper third of the esophagus is more commonly associated with squamous cell carcinoma, not adenocarcinoma.
**Option B:** The middle third of the esophagus can be affected by both squamous cell carcinoma and adenocarcinoma, but it is not the most common site for adenocarcinoma.
**Option D:** The cervical esophagus is primarily involved in squamous cell carcinoma, not adenocarcinoma.

**Clinical Pearl / High-Yield Fact**
The development of esophageal adenocarcinoma is strongly linked to chronic GERD and Barrett's esophagus. Early detection and treatment of GERD, as well as surveillance of Barrett's esophagus, are crucial for preventing the progression to adenocarcinoma.

**Correct Answer: C. The lower third of the esophagus, specifically the gastroesophageal junction (GEJ).**